Rainbow Rare Earths sees competitive advantage in new separation technology for Phalaborwa project. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

IN BRIEF: Futura progressing US regulatory submission for MED3000

Wed, 15th Sep 2021 20:23

Futura Medical PLC - Surrey-based pharmaceutical company - Says the first patient visit has occurred in the confirmatory clinical study, FM71, for MED3000 that will be supporting the US regulatory submission for the product. MED3000 is a breakthrough, fast acting topical gel formulation for the treatment of erectile dysfunction.

Says start of FM71 is in line with planning and both the FM71 and non-clinical human factors studies are now progressing in parallel targeting patient completion by the end of the second quarter of 2022 in order for submission of MED3000 for US regulatory approval as a DeNovo medical device for ED treatment, with over-the-counter classification by end the third quarter 2022. US marketing authorisation therefore remains on track for approval of MED3000 in first quarter of 2023.

Current stock price: 39.90 pence

Year-to-date change: more than double

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

Related Shares

More News

IN BRIEF: Futura progressing US regulatory submission for MED3000

IN BRIEF: Futura progressing US regulatory submission for MED3000

15 Sep 21 20:23

TRADING UPDATES: Sanderson Selfridges deal; Cazoo ups Forward Partners

TRADING UPDATES: Sanderson Selfridges deal; Cazoo ups Forward Partners

1 Sep 21 20:56

Futura enters erection gel licensing deal with M8

(Sharecast News) - Futura Medical has entered into a licensing agreement with M8 Pharmaceuticals, a specialty biopharmaceutical company focused on commercialisation in Latin America, for the rights to exclusively develop and commercialise its topical, gel-based erectile dysfunction (ED) treatment MED3000 in Brazil and Mexico, it announced on Tuesday.

31 Aug 21 15:08

TRADING UPDATES: Sareum raises GBP1 million; Marlowe buys Core Stream

TRADING UPDATES: Sareum raises GBP1 million; Marlowe buys Core Stream

19 Jul 21 19:13

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.